E, E., M, S., C, R., V, M., E, S., & M, M. (2020). High biochemical recurrence rate after withdrawal of cabergoline in prolactinomas: Is it necessary to restart treatment? Endocrine, 70(1), 143. https://doi.org/10.1007/s12020-020-02388-0
Chicago Style (17th ed.) CitationE, Espinosa-Cárdenas, Sánchez-García M, Ramírez-Rentería C, Mendoza-Zubieta V, Sosa-Eroza E, and Mercado M. "High Biochemical Recurrence Rate After Withdrawal of Cabergoline in Prolactinomas: Is It Necessary to Restart Treatment?" Endocrine 70, no. 1 (2020): 143. https://doi.org/10.1007/s12020-020-02388-0.
MLA (9th ed.) CitationE, Espinosa-Cárdenas, et al. "High Biochemical Recurrence Rate After Withdrawal of Cabergoline in Prolactinomas: Is It Necessary to Restart Treatment?" Endocrine, vol. 70, no. 1, 2020, p. 143, https://doi.org/10.1007/s12020-020-02388-0.